Oral hormonal contraceptives Archives - Revista Brasileira de Ginecologia e Obstetrícia

  • Review Article01-11-2023

    Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review

    Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(12):818-823

    Abstract

    Review Article

    Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review

    Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(12):818-823

    DOI 10.1055/s-0043-1776403

    Views367

    Abstract

    Cervical cancer (CC) is caused by persistent infection of human papillomavirus of high oncogenic risk (hr-HPV); however, several cofactors are important in its carcinogenesis, such as smoking, multiparity, and prolonged use of oral hormonal contraceptives (COCs). Worldwide, 16% of women use COCs, whereas in Brazil this rate is of ~ 30%. The safety and adverse effects of COCs are widely discussed in the literature, including the increase in carcinogenic risk. Due to the existence of several drugs, combinations, and dosages of COCs, it is hard to have uniform information in epidemiological studies. Our objective was to perform a narrative review on the role of COCs use in the carcinogenesis of cervical cancer. Several populational studies have suggested an increase in the incidence of cervical cancer for those who have used COCs for > 5 years, but other available studies reach controversial and contradictory results regarding the action of COCs in the development of CC.

    See more
    This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Search

Search in:

Article type
Article type
abstract
book-review
brief-report
case-report
correction
editorial
letter
other
rapid-communication
research-article
review-article
Section
Section
Autors' Reply
Case Report
Clinical Consensus Recommendation
Editor's Note
Editorial
Equipments and Methods
Erratum
FEBRASGO POSITION STATEMENT
FIGO Statement
GUIDELINES
Integrative Review
Letter to the Editor
Nominata 2024
Original Article
Original Article/Contraception
Original Article/Infertility
Original Article/Obstetrics
Original Article/Oncology
Original Article/Sexual Violence/Pediatric and Adolescent Gynecology
Original Article/Teaching and Training
Previous Note
Reply to the Letter to the Editor
Resumos dos Trabalhos Premiados no 50º Congresso Brasileiro de Ginecologia e Obstetrícia
Review Article
Short Communication
Special Article
Systematic Review
Thesis Abstract
Year / Volume
Year / Volume
2025; v.47
2025; v.46
2024; v.46
2023; v.45
2022; v.44
2021; v.43
2020; v.42
2019; v.41
2018; v.40
2017; v.39
2016; v.38
2015; v.37
2014; v.36
2013; v.35
2012; v.34
2011; v.33
2010; v.32
2009; v.31
2008; v.30
2007; v.29
2006; v.28
2005; v.27
2004; v.26
2003; v.25
2002; v.24
2001; v.23
2000; v.22
1999; v.21
1998; v.20
ISSUE
ISSUE